Clinical Improvement of Alpha-mannosidosis Cat Following a Single Cisterna Magna Infusion of AAV1.
Lysosomal storage diseases (LSDs) are debilitating neurometabolic disorders for most of which long-term effective therapies have not been developed. Gene therapy is a potential treatment but a critical barrier to treating the brain is the need for global correction. We tested the efficacy of cisterna magna infusion of adeno-associated virus type 1 (AAV1) expressing feline alpha-mannosidase gene in the postsymptomatic alpha-mannosidosis (AMD) cat, a homologue of the human disease. Lysosomal alpha-mannosidase (MANB) activity in the cerebrospinal fluid (CSF) and serum were increased above the control values in untreated AMD cats. Clinical neurological signs were delayed in onset and reduced in severity. The lifespan of the treated cats was significantly extended. Postmortem histopathology showed resolution of lysosomal storage lesions throughout the brain. MANB activity in brain tissue was significantly above the levels of untreated tissues. The results demonstrate that a single cisterna magna injection of AAV1 into the CSF can mediate widespread neuronal transduction of the brain and meaningful clinical improvement. Thus, cisterna magna gene delivery by AAV1 appears to be a viable strategy for treatment of the whole brain in AMD and should be applicable to many of the neurotropic LSDs as well as other neurogenetic disorders.
Research Institute of the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Sea Young
SY
Yoon
W.F. Goodman Center for Comparative Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jessica H
JH
Bagel
W.F. Goodman Center for Comparative Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Patricia A
PA
O'Donnell
W.F. Goodman Center for Comparative Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Charles H
CH
Vite
Research Institute of the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.|W.F. Goodman Center for Comparative Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
John H
JH
Wolfe
D017668:Age of Onset; D000818:Animals; D001921:Brain / Q000201:enzymology; D002371:Cat Diseases / Q000473:pathology / Q000628:therapy*; D002415:Cats; D002946:Cisterna Magna / Q000378:metabolism*; D000229:Dependovirus / Q000235:genetics*; D004195:Disease Models, Animal; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000008:administration & dosage; D006801:Humans; D007267:Injections; D008247:Lysosomes / Q000378:metabolism; D043323:alpha-Mannosidase / Q000097:blood / Q000134:cerebrospinal fluid / Q000235:genetics* / Q000378:metabolism; D008363:alpha-Mannosidosis / Q000473:pathology / Q000628:therapy / Q000662:veterinary*
D043323:alpha-Mannosidase